ClinicalTrials.gg
CompletedNCT07906704Updated Oct 30, 2026

Intra-Operative Infrared Thermography for Bowel Resection

An interventional study of Intra-operative Infrared Thermography and Conventional visual assessment in Anastomotic Leak, Bowel Resection and Intestinal Ischemia, sponsored by Sir Ganga Ram Hospital. Completed at 1 site in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Sir Ganga Ram Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jan 2024, registered Oct 2026).
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This prospective randomized control pilot study evaluates the use of intra-operative infrared thermography compared to conventional visual assessment for preventing anastomotic leaks in bowel resection surgeries. Eighty adult patients undergoing elective single bowel resection and anastomosis were randomly divided into two equal groups. In the intervention group, a portable thermal camera was used to assess real-time blood supply at the bowel margins to decide the exact line of resection. In the control group, surgeons used standard clinical judgment based on visual cues. The primary outcome measured was the incidence of anastomotic leak within thirty days after surgery. Secondary outcomes evaluated included total operative time, intra-operative blood loss, length of hospital stay, thirty-day mortality, and post-operative complications graded by the Clavien-Dindo classification system.

02

Conditions studied

  • Anastomotic Leak
  • Bowel Resection
  • Intestinal Ischemia

Browse trials for

Keywords

  • Infrared Thermography
  • Bowel Perfusion
  • FLIR
  • Colorectal Surgery
03

In context

Anastomotic Leak

240 studies on the registry are indexed under Anastomotic Leak; 72 are open to participants now.

This study's enrollment of 80 is below the median of 140 across 128 interventional studies indexed under Anastomotic Leak.

Browse Anastomotic Leak studies →

Lead sponsor

Sir Ganga Ram Hospital is the lead sponsor of 30 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-Adult patients undergoing elective single bowel resection and primary anastomosis of the small or large intestine.

Exclusion criteria

Exclusion Criteria:

  • Patients for whom multiple resections and anastomoses were planned (e.g., colonic pull-up, Roux-en-Y configurations).
  • Construction of surgical pouches (e.g., Ileal Pouch-Anal Anastomosis).
  • Patients who did not provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    IRT Group

    Real-time perfusion evaluation using a portable thermal camera to determine the resection line

    Device: Intra-operative Infrared Thermography

  • Active comparator
    Control Group

    Adequacy of perfusion assessed exclusively through the surgeon's standard clinical judgment

    Procedure: Conventional visual assessment

Interventions

  • DeviceIntra-operative Infrared Thermography

    Use of a passive FLIR thermal camera to map surface temperatures and demarcate perfused from ischemic bowel segments

  • ProcedureConventional visual assessment

    Standard surgical assessment utilizing visual and tactile cues such as serosal color, palpable mesenteric pulsations, and active bleeding

06

What researchers measure

Primary outcomes

  1. Anastomotic Leak

    Incidence of clinically or radiologically confirmed anastomotic leak.

    Time frame: From date of surgery until hospital discharge, assessed up to 30 days

Secondary outcomes

  1. Operative Time

    Total duration of the surgery from skin incision to closure

    Time frame: Intra-operative

  2. Length of Hospital Stay

    Total days admitted in the hospital

    Time frame: Day of surgery to discharge

  3. Postoperative Complications

    Evaluated using the Clavien-Dindo classification system

    Time frame: Within 30 days postoperatively

  4. Mortality

    Incidence of death

    Time frame: Within 30 days postoperatively

07

Study locations

1 site
  • Sir Ganga Ram Hospital
    New Delhi, National Capital Territory of Delhi 110060, India
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07906704
Lead sponsor
Sir Ganga Ram Hospital
Responsible party
Dr Vidit Dholakia (Principal Investigator, Sir Ganga Ram Hospital) — Principal investigator
First posted
Oct 30, 2026
Start date
Jan 18, 2024
Primary completion
Apr 30, 2025
Completion
Apr 30, 2025
Last update
Oct 30, 2026

Study contacts

Vidit A Dholakia, MS,DrNB
principal investigator · Sir Ganga Ram Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion